Seizures can promote more seizures through maladaptive myelination, new findings suggest
New research in rodent models of generalized epilepsy has demonstrated that absence seizures, or brief, sudden lapses of consciousness, can cause abnormal changes in myelin plasticity, maladaptively l...
16 Tammi 202313min
The emergence of psychedelic-assisted therapies
In this episode, leading experts Tadeusz Hawrot, Psychedelic Access and Research European Alliance (PAREA); and Ellen James, PhD, Director of Research and Development, Small Pharma, London, UK, discus...
4 Tammi 202318min
Pregnancy management in MS and NMOSD
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are chronic conditions of the central nervous system, predominantly affecting women of childbearing age. Hence pregnancy pla...
25 Marras 20229min
Debating intravenous and intra-arterial thrombolysis use in ischemic stroke
In this podcast, stroke experts discuss the latest updates in recanalization therapy in acute ischemic stroke, highlighting the major debates that have the potential to change clinical practice. Both ...
17 Marras 202220min
MS genetics and environment: new findings
In this podcast, Sergio Baranzini, PhD, The University of California San Francisco, San Francisco, CA, discusses our current knowledge of the etiology of MS, the future of genetic studies, and interes...
31 Loka 202214min
Key trials in Huntington’s disease: SAGE-718, pridopidine, PTC518, & ANX005
In this week’s episode, specialists in the Huntington's disease (HD) field discuss the details of major ongoing studies and give an insight into the implications that their research could have for dis...
19 Loka 202220min
New horizons in hyperkinetic movement disorders
In this podcast, Sanjay Pandey, MD, Govind Ballabh Pant Hospital, New Delhi, India; Carlo Colosimo, MD, FEAN, Santa Maria University Hospital, Terni, Italy; and Marcelo Kauffman, MD, PhD, Hospital JM ...
13 Loka 202212min
Update on cenobamate: long-term and subgroup analyses
Cenobamate was approved by the FDA in 2019 and the EMA in 2021 for the adjunctive treatment of focal-onset seizures with or without secondary generalization in adult patients. Following its approval, ...
7 Loka 202226min
